Key result
Propofol administration for endoscopy by anesthetists in the United States is increasing costs, prompting a need for collaborative exploration of safe and cost-effective alternatives.
Highlights the need for gastroenterology and anesthesia communities to collaborate on safe and cost-effective mechanisms for propofol use in endoscopy.
May warrant cost scrutiny of anesthetist-led propofol in endoscopy; leaves open identification of safe alternatives via collaborative trials.
Propofol use for endoscopy is increasing rapidly. Its administration by registered nurses under the supervision of endoscopists has thus far proven safe, but is not realistically feasible in most U.S. endoscopy units. Therefore, propofol in the United States is being administered almost entirely by anesthetists. Transition to anesthetist-delivered sedation for endoscopy is being accompanied by increased costs, which in turn has the potential to adversely affect endoscopic practice. The gastroenterology and anesthesia communities should work together to explore mechanisms to expand propofol use or an alternative for endoscopy in a safe and cost-effective manner.
No takes yet. Share an insight, caveat, or question.
Douglas K. Rex (2004) conducted a review in Endoscopy sedation. Propofol administration was evaluated. Propofol administration for endoscopy by anesthetists in the United States is increasing costs, prompting a need for collaborative exploration of safe and cost-effective alternatives.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: